Use of data from patient records for research : a model for best practice? by Mathers, Nigel & Dobbs, Frank
Malta Medical Journal    Volume 19   Issue 01   March 2007 9
Nigel Mathers, Frank Dobbs
Review Article
Use of data from patient records for research: 
a model for best practice?
Nigel Mathers*
Professor of Primary Medical Care and 
Director of Academic Unit of Primary Medical Care, 
University of Sheffield
Email:  n.mathers@sheffield.ac.uk
Frank Dobbs
Director of Postgraduate Medicine and Primary Care
University of Ulster
Key words
patient, records, research
* corresponding author
Introduction
In the UK National Health Service (NHS), the registered list 
and the clinical records of patients are an invaluable resource 
for the quality assurance of clinical care in General Practice 
(e.g. audit) and for service development and quality initiatives. 
These records are also powerful instruments for the conduct 
of research in primary care.  General practitioners are the 
“guardians” of these demographic and clinical data and, indeed, 
the use of patient data from these records for research in the 
past has given us many examples of excellent research which 
have had a direct impact on the care of our patients and the 
advice we give them. 
For example, a classic study of over 40,000 people which 
linked GP prescriptions with data on hospital admissions and 
deaths was able to show a highly significant association between 
the use of minor tranquilisers (e.g. diazepam) and the risk 
of serious road traffic accidents. Patients were not contacted 
during this study and their clinical records were accessed 
without consent.1 
The current policy of the Royal College of General 
Practitioners (RCGP) UK is that patients should be required to 
opt in to the use of their personal and clinical data for research 
projects rather than the alternative arrangements whereby 
patients are asked to opt out of participation in research 
projects. Such arrangements for the participation of patients 
in research have a direct impact, not only on the opportunities 
for research in general practice but also on the conduct of that 
research. 
An example of the impact which ‘opting in’ and ‘opting 
out’ arrangements can have on participation in research may 
be seen in a recent study concerned with the management of 
patients with angina.2 Half of the patients were randomised to 
‘opting in’ whereby they only took part in the study if they got in 
touch with the researchers to say they wished to take part. The 
other half were randomised to ‘opting out’ whereby they were 
approached again by the research team and could decline to 
take part if they wished to. The ‘opt in’ route resulted in a lower 
participation rate and a biased sample with fewer coronary 
heart disease risk factors, less treatment and less disability as a 
result of their angina. The authors conclude that giving patients 
the opportunity to ‘opt out’ is a better method of recruiting a 
representative sample of patients than studies involving patients 
who ‘opt in’.
The UK Academy of Medical Sciences report 
(AMS)
A recent Academy of Medical Sciences (UK) report “Personal 
data for public good: using health information in medical 
research” has stimulated the current debate on how personal 
data in routine clinical records may be used for research 
without consent.3 
Personal data in this report are defined as data which relate 
to a living individual who can be identified from those data, and 
which can be used for medical research. Such data may include 
information on health (e.g. clinical data) or non-health issues 
(e.g. postcode or date of birth).
The AMS report highlights the present legal state of affairs 
in the UK where the law allows the use of identifiable data for 
medical research without consent, provided that such use is 
necessary and proportionate with respect to privacy and 
public interest benefits. 
0 Malta Medical Journal    Volume 19   Issue 01   March 2007
In contrast to this approach, however, the professional 
colleges in the UK (e.g. the RCGP) have maintained a policy of 
requiring “consent or anonymisation.”
The question which needs to be considered now is whether 
this policy of consent or anonymisation should be reviewed 
in order to facilitate general practice research which could 
not be done otherwise, and if there is sufficient benefit to 
counterbalance any small reduction in privacy.  This question 
is not about reducing the requirements for informed consent for 
invasive research which will alter the management of patients. 
It is about allowing the use of personal data held within routine 
clinical records for research, without the specific consent of the 
patient that it may be used for this purpose, but with safeguards 
to protect them from infringement of privacy.
Consent or anonymisation?
The AMS report recommends that the safe use of identifiable 
data should rely on adequate data security policies rather than 
a policy of anonymisation. It also recommends that explicit 
consent to the use of identifiable patient data should always 
be sought in circumstances when seeking that consent is both 
feasible and proportionate. Where this is not the case, data 
should only be used within the context of a strict data security 
policy and in situations where the benefits outweigh possible 
disadvantages. 
One of the issues which is raised by such a policy, however, 
is that of patients’ trust in their doctors – the annual MORI 
survey of UK residents in 2006, for example, revealed that the 
most trusted profession are doctors (92% of the population 
trust them) closely followed by teachers (88%). By contrast, 
politicians and journalists were only trusted by 20% and 19% 
of respondents respectively.4 The doctor-patient relationship is 
one of the most important factors supporting high-quality care 
in general practice and trust is the central component of this. 
Clearly, the use of personal (identifiable) data from the clinical 
records of our patients for research purposes without consent 
could potentially threaten our relationship with our patients. 
Consideration of any policy changes, therefore, needs to place 
this concern at the centre of the discussion.
However, if such data security policies were to be introduced 
into general practice, it is clear that a model of best practice 
for data security needs to be developed – for example, not only 
by identifying how health records can be accessed but also by 
clearly stating who should have access to those health records 
and which data can be shared with non-clinical primary care 
researchers. 
The case for research on anonymised 
record databases
An alternative to using identifiable GP patient records 
for large population research is provided by the anonymised 
UK record databases General Practice Research Database 
[GPRD](10.1 million patients)5 and QResearch6 (about half 
the size of GPRD). Most epidemiological research which could 
be done on identifiable records, can also be done on these 
anonymised databases. The GPRD data is downloaded regularly 
from 962 GP practices which use the “VAMP” Vision Patient 
Data Management System (PDMS). QResearch data comes from 
practices with the “EMIS” PDMS. 
Tight control of permission to carry out studies is maintained 
by the organising bodies. Studies must be of acceptable quality 
and have a clear research question. Although database data are 
pseudo-anonymised, allowing updating of records over time, no 
identifiable data leaves the GP practice. Only subsets of data 
are released to researchers, sufficient to answer the specific 
question posed. Consequently the chances of infringement of 
confidentiality are minimised.
GPRD is available without charge to all health service 
researchers in the UK due to financial support from the Medical 
Research Council. QResearch is a not-for-profit organisation 
and charges a small fee for data access.
Engaging the public
Consultation with patients and patient representatives 
reveals strong support for research using personal data at 
present, with confidence expressed in the integrity of research 
practices and their general practitioners. In a recent study by 
Barrett et al (2006), for example, on the use of medical records 
and registration for cancer research, interviews were carried out 
in a large random sample of UK homes. Participants were given 
a full explanation of the purpose of the research before being 
asked their opinion. The majority of participants supported the 
use of their personal data for cancer research and registration, 
provided confidentiality and security were assured.6
It is clear that if general practice research is to be carried 
out under a policy of data security as proposed by the AMS, 
then public engagement about the value of that research using 
health care records needs to be enlisted, and the arrangements 
under which records are held and accessed made explicit. 
This is particularly important with the advent of the NHS 
IT programme, ‘Connecting for Health’, whereby access to 
identifiable patient date (clinical records) will be available 
to health care workers in all parts of the UK as part of their 
clinical care.8 
It is important, therefore, for primary care researchers 
and general practitioners not only to engage the public 
around the benefits of research involving personal data but 
also to demonstrate that high standards of confidentiality are 
consistently applied. Providing the public with specific examples 
of research which has directly improved the care of patients 
is also important.  This can be supported by including such 
examples within a model for best practice in this area. 
The robustness of the procedures for research governance 
and data handling must also be shared with people in the 
community, so that they can be happy with the balancing of 
confidentiality and the availability of data for analysis with 
improvements in health outcomes.  There are, of course, many 
effective safeguards in place already to protect patients in 
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Europe from inappropriate use of their data in research.  In the 
UK, these include the RCGP ‘Research Ready’ criteria and the 
current NHS Research Governance requirements. 
Good Practice Guidance
The AMS, the UK Clinical Research Collaboration (UK CRC) 
and the Medical Research Council (MRC, UK), along with a 
number of other concerned bodies are, at the time of writing, 
contributing to the development of a model for Good Practice 
Guidance which will ‘encompass issues related to data security, 
anonymisation, consent and the use of health records to identify 
research participants’.3
 Such guidance should provide not only practical guidance 
for practitioners but also a set of practical exemplars around 
which researchers can develop research proposals. This guidance 
could provide valuable assistance to general practitioners and 
other primary care researchers as well as to organisations 
involved with the governance and management of research in 
primary care. 
For example, there are likely to be two major uses of 
identifiable patient data without consent in primary care 
research. The first is for secondary research on data collected 
for routine medical care, and the second is for the recruitment 
of patients to primary research studies. 
Further examples can be found in the MRC guidance 
document on Personal Information in Medical Research.9
From this discussion, therefore, a model for good practice 
guidance for the use of patient data in general practice research 
is essential.  The AMS report recommends that it should include 
the following components:
1.   Data security and anonymisation
• Methods for data security (physical, technical and 
procedural security).
• Rigorous specification of who is appropriate to carry 
out anonymisation or pseudonymisation procedures 
and under what circumstances.
• Identification of who holds the encryption key and how 
access to data is managed.
2.   Consent
• Methods for assessing the risk of introducing bias by 
requiring consent which may endanger the validity of 
results.
• Estimation of the proportion of a population who 
may be untraceable or not easily contactable to obtain 
consent.
• Assessment of overall financial and time burdens 
imposed and the risk of inflicting harm or distress by 
contacting people.
3.   Use of health records 
       to identify research participants
• Identification of the conditions and procedure by 
which health records may be accessed at start of 
research process.
• Specification of the mechanisms for contacting 
potential study recruits and for registering agreement 
or refusal to participate.
The way forward
It is clear that a shift of policy from “opting in” or “opting 
out” of participation in research projects towards a policy 
which focuses on data security policies rather than consent or 
anonymisation issues has profound implications for researchers, 
practitioners and patients.  The issues are complex even without 
detailed ethical consideration, but it is essential that we continue 
this debate right across Europe so that we can begin to develop 
some consensus on how identifiable (‘personal’) patient data 
can and should be used in general practice research without 
infringing the doctor-patient relationship.
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